<DOC>
	<DOCNO>NCT02028208</DOCNO>
	<brief_summary>The purpose study compare ascend dos investigational T.R.U.E . Test allergens market petrolatum reference allergen .</brief_summary>
	<brief_title>Clinical Evaluation Metal Panel Allergens : Mercury , Aluminum Palladium Dose Response Study</brief_title>
	<detailed_description>This single-center , double-blind , randomize study compare diagnostic performance ( primary ) safety ( secondary ) ascend doses mercury , aluminum palladium 20 adult subject clinical history contact dermatitis test positive ( current previous patch test ) least one allergens test .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<criteria>1.15 year age old . 2 . History contact dermatitis . 3 . Positive patch result 1 ) mercury ( elemental ) , 2 ) aluminum ( aluminum chloride hexahydrate , aluminum hydroxide and/or aluminum lactate ) 3 ) palladium ( sodium tetrachloropalladate and/or palladium chloride ) within past 10 year . 4 . Male nonpregnant nonlactating female . Female subject must state , visit one pregnant , lactate intend become pregnant course study . 5 . Has understood sign approve Informed Consent/Assent Form , consistent institutional , local national regulation . Assent Form minor subject ( age 1517 ) must sign guardian/parent . 1 . Breastfeeding pregnant intend become pregnant course study . 2 . Topical treatment corticosteroid immunosuppressive agent near test area 7 day prior inclusion study . 3 . Systemic treatment corticosteroid ( equivalent &gt; 10 mg prednisone ) immunosuppressive agent 7 day prior inclusion study . Inhaled treatment permit . 4 . Treatment ultraviolet ( UV ) light ( include tan ) 3 week prior inclusion study . 5 . Acute dermatitis outbreak dermatitis near test area back . 6 . Inability comply patch test study requirement include multiple return visit activity restriction ( e.g. , protect test panel excess moisture due shower vigorous activity ) . 7 . Participation clinical trial investigational drug , treatment device T.R.U.E . TEST study 3 week prior inclusion study . 8 . An opinion Investigator deem potential subject noncompliant , unable return study visit complete study detail protocol .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Patch Test</keyword>
	<keyword>Allergy Testing</keyword>
	<keyword>Contact Dermatitis</keyword>
	<keyword>Mercury , Aluminum Palladium skin allergy</keyword>
</DOC>